AU2018260865A1 - Multidirectional mucosal delivery devices and methods of use - Google Patents

Multidirectional mucosal delivery devices and methods of use Download PDF

Info

Publication number
AU2018260865A1
AU2018260865A1 AU2018260865A AU2018260865A AU2018260865A1 AU 2018260865 A1 AU2018260865 A1 AU 2018260865A1 AU 2018260865 A AU2018260865 A AU 2018260865A AU 2018260865 A AU2018260865 A AU 2018260865A AU 2018260865 A1 AU2018260865 A1 AU 2018260865A1
Authority
AU
Australia
Prior art keywords
multidirectional
methods
delivery devices
mucosal delivery
transmucosal delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018260865A
Inventor
Andrew Finn
Niraj Vasisht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biodelivery Sciences International Inc
Original Assignee
Biodelivery Sciences International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009271271A external-priority patent/AU2009271271A1/en
Application filed by Biodelivery Sciences International Inc filed Critical Biodelivery Sciences International Inc
Priority to AU2018260865A priority Critical patent/AU2018260865A1/en
Publication of AU2018260865A1 publication Critical patent/AU2018260865A1/en
Priority to AU2020220105A priority patent/AU2020220105A1/en
Abandoned legal-status Critical Current

Links

Abstract

1: \rbr\Interwoven\NRPortbl\DCC\RBR\14670119_l.docx-2 06/2017 The present invention relates to a pharmaceutical dosage form for transmucosal delivery of an active agent to two or more mucosal surfaces. The dosage form is presented as a transmucosal delivery device. The devices of the invention may include at least two mucoadhesive surfaces. The devices may further include an intermediate layer disposed between the mucoadhesive layers. The pharmaceutical can be incorporated in any one or all of the mucoadhesive layers or the intermediate layer. Upon application, the device adheres to at least two surfaces, providing transmucosal delivery of the drug to at least two surfaces.
AU2018260865A 2008-06-23 2018-11-07 Multidirectional mucosal delivery devices and methods of use Abandoned AU2018260865A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2018260865A AU2018260865A1 (en) 2008-06-23 2018-11-07 Multidirectional mucosal delivery devices and methods of use
AU2020220105A AU2020220105A1 (en) 2008-06-23 2020-08-19 Multidirectional mucosal delivery devices and methods of use

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US61/074,918 2008-06-23
AU2009271271A AU2009271271A1 (en) 2008-06-23 2009-06-23 Multidirectional mucosal delivery devices and methods of use
AU2015203167A AU2015203167A1 (en) 2008-06-23 2015-06-04 Multidirectional mucosal delivery devices and methods of use
AU2017203749A AU2017203749A1 (en) 2008-06-23 2017-06-02 Multidirectional mucosal delivery devices and methods of use
AU2018260865A AU2018260865A1 (en) 2008-06-23 2018-11-07 Multidirectional mucosal delivery devices and methods of use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2017203749A Division AU2017203749A1 (en) 2008-06-23 2017-06-02 Multidirectional mucosal delivery devices and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2020220105A Division AU2020220105A1 (en) 2008-06-23 2020-08-19 Multidirectional mucosal delivery devices and methods of use

Publications (1)

Publication Number Publication Date
AU2018260865A1 true AU2018260865A1 (en) 2018-11-22

Family

ID=53570972

Family Applications (4)

Application Number Title Priority Date Filing Date
AU2015203167A Abandoned AU2015203167A1 (en) 2008-06-23 2015-06-04 Multidirectional mucosal delivery devices and methods of use
AU2017203749A Abandoned AU2017203749A1 (en) 2008-06-23 2017-06-02 Multidirectional mucosal delivery devices and methods of use
AU2018260865A Abandoned AU2018260865A1 (en) 2008-06-23 2018-11-07 Multidirectional mucosal delivery devices and methods of use
AU2020220105A Abandoned AU2020220105A1 (en) 2008-06-23 2020-08-19 Multidirectional mucosal delivery devices and methods of use

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AU2015203167A Abandoned AU2015203167A1 (en) 2008-06-23 2015-06-04 Multidirectional mucosal delivery devices and methods of use
AU2017203749A Abandoned AU2017203749A1 (en) 2008-06-23 2017-06-02 Multidirectional mucosal delivery devices and methods of use

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2020220105A Abandoned AU2020220105A1 (en) 2008-06-23 2020-08-19 Multidirectional mucosal delivery devices and methods of use

Country Status (1)

Country Link
AU (4) AU2015203167A1 (en)

Also Published As

Publication number Publication date
AU2020220105A1 (en) 2020-09-03
AU2015203167A1 (en) 2015-07-02
AU2017203749A1 (en) 2017-06-22

Similar Documents

Publication Publication Date Title
BRPI0915386B8 (en) Device for delivering an active agent through the mucosa
WO2008011194A3 (en) Transmucosal delivery devices with enhanced uptake
WO2007125545A3 (en) Transmucosal composition
UA88464C2 (en) Method of topical methadone administration providing systemic effect
NZ586588A (en) Formulation of ( follice stimulating hormone) fsh and varients with benzalkonium chloride and benzyl alcohol
MX2010004265A (en) Composition for administering an active ingredient and method for making and using the same.
WO2007070632A3 (en) Abuse resistant transmucosal drug delivery device
WO2008146178A3 (en) A novel tablet dosage form
WO2014186742A3 (en) Anhydrous hydrogel composition
MX2012003082A (en) Pharmaceutical compositions for reducing alcohol-induced dose dumping.
WO2010042471A3 (en) Medical devices for delivery of therapeutic agents to body lumens
ATE474564T1 (en) SMALL VOLUME, ORAL, TRANSMUCOSAL DOSAGE FORMS OF SUFENTANIL FOR PAIN TREATMENT
MX2009000730A (en) Controlled release formulations and associated methods.
WO2010070675A3 (en) Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
PL2081547T3 (en) Galenic form for the trans-mucosal delivery of active ingredients
WO2007143155A3 (en) Sustained release pharmaceutical dosage form containing phenylephrine
WO2010121177A3 (en) Pharmaceutically active compositions comprising oxidative stress modulators (osm), new chemical entities, compositions and uses
MY163809A (en) Transdermal drug delivery system containing donepezil
WO2014130866A3 (en) Targeted buccal delivery comprising cisplatin-loaded chitosan nanoparticles
CL2011003327A1 (en) Pharmaceutical composition comprising finafloxacin and an anti-inflammatory agent; use in the treatment of ophthalmic, otic or nasal infections.
IL192611A0 (en) Biologically active composition comprising ethylcellulose
MX2015007678A (en) Transmucosal delivery of glatiramer acetate.
WO2011140446A3 (en) Pharmaceutical formulations
WO2010019611A3 (en) Bridged polycyclic compound based compositions for topical and oral applications
WO2014100643A8 (en) Oral transmucosal delivery of glatiramer acetate

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted